Roivant Sciences
ROIV
ROIV
436 hedge funds and large institutions have $14.7B invested in Roivant Sciences in 2026 Q1 according to their latest regulatory filings, with 92 funds opening new positions, 171 increasing their positions, 121 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
10% more funds holding
Funds holding: 396 → 436 (+40)
0.91% more ownership
Funds ownership: 73.16% → 74.06% (+0.91%)
0% more funds holding in top 10
Funds holding in top 10: 14 → 14 (0)
Holders
436
Holding in Top 10
14
Calls
$42M
Puts
$32M
Top Buyers
| 1 | +$313M | |
| 2 | +$248M | |
| 3 | +$175M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$130M |
| 5 |
National Bank of Canada
Montreal,
Quebec, Canada
|
+$109M |
Top Sellers
| 1 | -$353M | |
| 2 | -$168M | |
| 3 | -$103M | |
| 4 |
JFG
Jefferies Financial Group
New York
|
-$90.1M |
| 5 |
O
OrbiMed
New York
|
-$47.5M |